• Leonardo Kapural, Nagy A Mekhail, Shrif Costandi, Christopher Gilmore, Jason E Pope, Sean Li, Corey W Hunter, Lawrence Poree, Peter S Staats, Rod S Taylor, Sam Eldabe, Jan Willem Kallewaard, Simon Thomson, Erika A Petersen, Dawood Sayed, Timothy R Deer, Ajay Antony, Ryan Budwany, Angela Leitner, Nicole Soliday, Rui V Duarte, and Robert M Levy.
• Carolinas Pain Institute, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
• Reg Anesth Pain Med. 2024 Apr 2; 49 (4): 233240233-240.

IntroductionChronic pain patients may experience impairments in multiple health-related domains. The design and interpretation of clinical trials of chronic pain interventions, however, remains primarily focused on treatment effects on pain intensity. This study investigates a novel, multidimensional holistic treatment response to evoked compound action potential-controlled closed-loop versus open-loop spinal cord stimulation as well as the degree of neural activation that produced that treatment response.MethodsOutcome data for pain intensity, physical function, health-related quality of life, sleep quality and emotional function were derived from individual patient level data from the EVOKE multicenter, participant, investigator, and outcome assessor-blinded, parallel-arm randomized controlled trial with 24 month follow-up. Evaluation of holistic treatment response considered whether the baseline score was worse than normative values and whether minimal clinical important differences were reached in each of the domains that were impaired at baseline. A cumulative responder score was calculated to reflect the total minimal clinical important differences accumulated across all domains. Objective neurophysiological data, including spinal cord activation were measured.ResultsPatients were randomized to closed-loop (n=67) or open-loop (n=67). A greater proportion of patients with closed-loop spinal cord stimulation (49.3% vs 26.9%) were holistic responders at 24-month follow-up, with at least one minimal clinical important difference in all impaired domains (absolute risk difference: 22.4%, 95% CI 6.4% to 38.4%, p=0.012). The cumulative responder score was significantly greater for closed-loop patients at all time points and resulted in the achievement of more than three additional minimal clinical important differences at 24-month follow-up (mean difference 3.4, 95% CI 1.3 to 5.5, p=0.002). Neural activation was three times more accurate in closed-loop spinal cord stimulation (p<0.001 at all time points).ConclusionThe results of this study suggest that closed-loop spinal cord stimulation can provide sustained clinically meaningful improvements in multiple domains and provide holistic improvement in the long-term for patients with chronic refractory pain.Trial Registration NumberNCT02924129.© American Society of Regional Anesthesia & Pain Medicine 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.

13 keywords...

hide…